Our decision-making process
Some medications on our preferred drug list need prior authorization before they can be dispensed. First, you’ll request prior authorization for a member’s medication. Then, we’ll review your request and make our decision using the Department of Health Care Services’ prior authorization guidelines as well as our own custom guidelines.
Here are some of the guidelines that we use in our decision making:
Advate, Hemofil M, Kogenate FS, Novoeight, Recombinate, Xyntha (PDF)
Adynovate, Altuviiio, Eloctate, Esperoct (PDF)
Afstyla, Kovaltry, Nuwiq (PDF)
Atypical Antipsychotics Oral and Transdermal (PDF)
CGRP Antagonist Injectable IV Infusion (PDF)
Compounded Drug Products (PDF)
Continuous Glucose Monitor (PDF)
Disposable insulin pumps (PDF)
Eltrombopag olamine and Alvaiz (PDF)
Epogen - Procrit - Retacrit (PDF)
Epoprostenol-Flolan-Veletri (PDF)
Fentanyl - Oral and Intranasal
Immune Globulin Intravenous (PDF)
Immune Globulin Subcutaneous (PDF)
Infliximab Remicade and Biosimilar (PDF)
Lupron Depot Endometriosis - Fibroids (PDF)
Lupron Depot Prostate Cancer (PDF)
Methylphenidate Products (PDF)
Neulasta and pegfilgrastim biosimilars (PDF)
Neupogen and filgrastim biosimilars (PDF)
Nitroglycerin 0.4 percent ointment (PDF)
Opioids extended-release (PDF)
Opioids immediate-release (PDF)
Proton Pump Inhibitors Post Limit (PDF)
Radicava oral suspension (PDF)
Ranolazine Extended Release (PDF)
Tadalafil (Cialis & Chewtadzy) for BPH (PDF)
For more information
If you have questions or would like a copy of these guidelines sent to you, call Provider Services at
1-866-329-4701 (TTY: 711).